SES AI CORP, 10-Q filed on 8/6/2025
Quarterly Report
v3.25.2
Document and Entity Information - $ / shares
6 Months Ended
Jun. 30, 2025
Jul. 30, 2025
Document Information [Line Items]    
Entity Central Index Key 0001819142  
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2025  
Document Transition Report false  
Securities Act File Number 001-39845  
Entity Registrant Name SES AI Corporation  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 88-0641865  
Entity Address, Address Line One 35 Cabot Road  
Entity Address, City or Town Woburn  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 01801  
City Area Code 339  
Local Phone Number 298-8750  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Common Class A    
Document Information [Line Items]    
Title of 12(b) Security Class A common stock, par value $0.0001 per share  
Entity Listing, Par Value Per Share $ 0.0001  
Trading Symbol SES  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   321,839,570
Common Class B    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   43,881,251
Warrant    
Document Information [Line Items]    
Title of 12(b) Security Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share  
Trading Symbol SES WS  
Security Exchange Name NYSE  
v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 11,757 $ 128,796
Short-term investments 217,123 133,748
Accounts receivable 3,009 950
Inventories 114 212
Prepaid expenses and other assets 10,960 13,198
Total current assets 242,963 276,904
Property and equipment, net 34,089 38,165
Intangible assets, net 1,153 1,217
Right-of-use assets, net 8,744 9,927
Deferred tax assets 1,335 1,335
Other assets, non-current 2,176 2,237
Total assets 290,460 329,785
Current Liabilities    
Accounts payable 1,981 1,901
Operating lease liabilities 2,732 2,585
Accrued expenses and other current liabilities 14,788 18,329
Total current liabilities 19,501 22,815
Sponsor Earn-Out liabilities 3,036 9,472
Operating lease liabilities, non-current 6,573 7,977
Unearned government grant 9,509 8,606
Other liabilities, non-current 2,614 2,605
Total liabilities 41,233 51,475
Commitments and contingencies (Note 10)
Stockholders' Equity    
Common stock: Class A shares, $0.0001 par value, 2,100,000,000 shares authorized; 322,168,676 and 317,676,034 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively; Class B shares, $0.0001 par value, 200,000,000 shares authorized; 43,881,251 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively 37 36
Additional paid-in capital 585,688 579,378
Accumulated deficit (333,954) (298,871)
Accumulated other comprehensive loss (2,544) (2,233)
Total stockholders' equity 249,227 278,310
Total liabilities and stockholders' equity $ 290,460 $ 329,785
v3.25.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2025
Dec. 31, 2024
Common Class A    
Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 2,100,000,000 2,100,000,000
Common stock, shares issued (in shares) 322,168,676 317,676,034
Common stock, shares outstanding (in shares) 322,168,676 317,676,034
Common Class B    
Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 43,881,251 43,881,251
Common stock, shares outstanding (in shares) 43,881,251 43,881,251
v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue from contracts with customers:        
Revenue $ 3,527   $ 9,320  
Cost of revenues 927   2,163  
Gross profit 2,600   7,157  
Operating expenses:        
Research and development 19,087 $ 15,057 39,597 $ 26,822
General and administrative 6,520 9,570 13,840 19,076
Total operating expenses 25,607 24,627 53,437 45,898
Loss from operations (23,007) (24,627) (46,280) (45,898)
Other income:        
(Loss) Gain on change in fair value of Sponsor Earn-Out liabilities (1,443) 1,411 6,436 2,286
Interest income 2,367 3,995 5,037 8,157
Miscellaneous income (expense), net 100 (580) 396 294
Total other income, net 1,024 4,826 11,869 10,737
Loss before income taxes (21,983) (19,801) (34,411) (35,161)
Provision for income taxes (668) (96) (672) (293)
Net loss (22,651) (19,897) (35,083) (35,454)
Other comprehensive loss, net of tax:        
Foreign currency translation adjustment (283) (93) (236) (550)
Unrealized loss on short-term investments (55) (59) (75) (358)
Total other comprehensive loss, net of tax (338) (152) (311) (908)
Total comprehensive loss $ (22,989) $ (20,049) $ (35,394) $ (36,362)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (0.07) $ (0.06) $ (0.11) $ (0.11)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (0.07) $ (0.06) $ (0.11) $ (0.11)
Weighted-average shares outstanding, basic (in shares) 331,731,923 320,833,854 330,539,801 319,812,287
Weighted-average shares outstanding, diluted (in shares) 331,731,923 320,833,854 330,539,801 319,812,287
v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2023 $ 35 $ 559,214 $ (198,686) $ (1,613) $ 358,950
Beginning balance (in shares) at Dec. 31, 2023 354,148,173        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options   18     18
Issuance of common stock upon exercise of stock options (in shares) 197,127        
Restricted stock units vested (in shares) 18,869        
Forfeitures of Earn-Out Restricted Shares (in shares) (711,298)        
Forfeitures of Restricted Stock Awards   (50)     (50)
Forfeitures of Restricted Stock Awards (in shares) (35,253)        
Stock-based compensation   4,784     4,784
Net loss     (15,557)   (15,557)
Unrealized loss on short-term investments       (299) (299)
Foreign currency translation adjustments       (457) (457)
Ending balance at Mar. 31, 2024 $ 35 563,966 (214,243) (2,369) 347,389
Ending balance (in shares) at Mar. 31, 2024 353,617,618        
Beginning balance at Dec. 31, 2023 $ 35 559,214 (198,686) (1,613) 358,950
Beginning balance (in shares) at Dec. 31, 2023 354,148,173        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (35,454)
Unrealized loss on short-term investments         (358)
Foreign currency translation adjustments         (550)
Ending balance at Jun. 30, 2024 $ 35 568,199 (234,140) (2,521) 331,573
Ending balance (in shares) at Jun. 30, 2024 355,906,935        
Beginning balance at Mar. 31, 2024 $ 35 563,966 (214,243) (2,369) 347,389
Beginning balance (in shares) at Mar. 31, 2024 353,617,618        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options   110     110
Issuance of common stock upon exercise of stock options (in shares) 746,517,000        
Restricted stock units vested   (635)     (635)
Restricted stock units vested (in shares) 1,653,403        
Forfeitures of Earn-Out Restricted Shares (in shares) (77,529)        
Forfeitures of Restricted Stock Awards   (44)     (44)
Forfeitures of Restricted Stock Awards (in shares) (33,074)        
Stock-based compensation   4,802     4,802
Net loss     (19,897)   (19,897)
Unrealized loss on short-term investments       (59) (59)
Foreign currency translation adjustments       (93) (93)
Ending balance at Jun. 30, 2024 $ 35 568,199 (234,140) (2,521) 331,573
Ending balance (in shares) at Jun. 30, 2024 355,906,935        
Beginning balance at Dec. 31, 2024 $ 36 579,378 (298,871) (2,233) 278,310
Beginning balance (in shares) at Dec. 31, 2024 361,557,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options   8     8
Issuance of common stock upon exercise of stock options (in shares) 50,000        
Restricted stock units vested (in shares) 3,284,079        
Forfeitures of Earn-Out Restricted Shares (in shares) (2,797)        
Forfeitures of Restricted Stock Awards   (31)     (31)
Forfeitures of Restricted Stock Awards (in shares) (37,735)        
Stock-based compensation   3,973     3,973
Net loss     (12,432)   (12,432)
Unrealized loss on short-term investments       (20) (20)
Foreign currency translation adjustments       47 47
Ending balance at Mar. 31, 2025 $ 36 583,328 (311,303) (2,206) 269,855
Ending balance (in shares) at Mar. 31, 2025 364,850,832        
Beginning balance at Dec. 31, 2024 $ 36 579,378 (298,871) (2,233) 278,310
Beginning balance (in shares) at Dec. 31, 2024 361,557,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (35,083)
Unrealized loss on short-term investments         (75)
Foreign currency translation adjustments         (236)
Ending balance at Jun. 30, 2025 $ 37 585,688 (333,954) (2,544) 249,227
Ending balance (in shares) at Jun. 30, 2025 366,049,927        
Beginning balance at Mar. 31, 2025 $ 36 583,328 (311,303) (2,206) 269,855
Beginning balance (in shares) at Mar. 31, 2025 364,850,832        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options $ 1 5     6
Issuance of common stock upon exercise of stock options (in shares) 74,311        
Restricted stock units vested (in shares) 1,184,478        
Forfeitures of Earn-Out Restricted Shares (in shares) (11,869)        
Forfeitures of Restricted Stock Awards   (327)     (327)
Forfeitures of Restricted Stock Awards (in shares) (47,825)        
Stock issuance costs   (13)     (13)
Stock-based compensation   2,695     2,695
Net loss     (22,651)   (22,651)
Unrealized loss on short-term investments       (55) (55)
Foreign currency translation adjustments       (283) (283)
Ending balance at Jun. 30, 2025 $ 37 $ 585,688 $ (333,954) $ (2,544) $ 249,227
Ending balance (in shares) at Jun. 30, 2025 366,049,927        
v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities    
Net loss $ (35,083) $ (35,454)
Adjustments to reconcile net loss to net cash used in operating activities:    
Gain from change in fair value of Sponsor Earn-Out liabilities (6,436) (2,286)
Stock-based compensation 6,686 9,586
Depreciation and amortization 5,043 3,666
Accretion income from available-for-sale short-term investments (1,734) (3,889)
Other 103 (1,478)
Changes in operating assets and liabilities:    
Receivable from related party   3,321
Accounts receivable (2,059)  
Inventories 103 22
Prepaid expenses and other assets 2,338 (2,548)
Right-of-use assets 1,272 1,802
Accounts payable (25) (274)
Lease liabilities (1,350) (1,715)
Accrued expenses and other liabilities (2,512) (1,824)
Net cash used in operating activities (33,654) (31,071)
Cash Flows From Investing Activities    
Purchases of property and equipment (1,720) (10,454)
Purchase of short-term investments (162,267) (133,999)
Proceeds from the maturities of short-term investments 80,800 145,000
Net cash (used in) provided by investing activities (83,187) 547
Cash Flows From Financing Activities    
Payments for taxes withheld to cover vested restricted stock (358)  
Proceeds from stock option exercises 13 128
Net cash (used in) provided by financing activities (345) 128
Effect of exchange rates on cash 199 (501)
Net decrease in cash, cash equivalents and restricted cash (116,987) (30,897)
Cash, cash equivalents and restricted cash at beginning of period (Note 5) 129,395 86,966
Cash, cash equivalents and restricted cash at end of period (Note 5) 12,408 56,069
Supplemental Cash and Non-Cash Information:    
Income taxes paid   203
Accounts payable and accrued expenses related to purchases of property and equipment $ 1,005 $ 2,081
v3.25.2
Nature of Business
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Business

Note 1.  Nature of Business

Organization

SES AI Corporation and its consolidated subsidiaries (together the “Company” or “SES”), is a leading developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (“Li-Metal”) and Lithium-ion (“Li-ion) rechargeable battery technologies for electric vehicles (“EVs”), Urban Air Mobility (“UAM”), drones, robotics, energy storage systems (“ESS”) and other applications. The Company’s mission is to accelerate the world’s energy transition through material discovery and battery management. The Company’s differentiated battery technology has been designed to combine the high energy density of Li-Metal with the cost-effective, large-scale manufacturability of conventional Li-ion batteries which will help to promote the transition from the global dependence on fossil fuel-based automotive vehicles to clean and efficient EVs. The Company’s headquarters are located in Woburn, Massachusetts with research and development facilities located there, in Shanghai, China, and in Chungju, South Korea. Principal operations have commenced, and the Company has derived revenue from its principal business activities starting in October 2024.

v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Basis of Presentation and Summary of Significant Accounting Policies

Note 2.  Basis of Presentation and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. Management believes that all adjustments necessary for the fair presentation of results, consisting of normally recurring items, have been included in the condensed consolidated financial statements for the interim periods presented. The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31.

The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited interim condensed consolidated financial statements do not include all of the annual disclosures required by U.S. GAAP; accordingly, they should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2025, as amended on April 30, 2025 (the “2024 Annual Report on Form 10-K”).

Use of estimates

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of commitments and contingencies, and the reported amounts of revenues, if any, and expenses. The Company bases its estimates on available historical experience and on various other factors that the Company believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from those estimates.

Significant estimates and assumptions include those related to the valuation of (i) certain equity awards, including common stock awards prior to the Business Combination, the Sponsor Earn-Out Shares, the Earn-Out Restricted Shares, and performance stock units, (ii) revenue from customers, (iii) deferred tax assets and uncertain income tax positions, (iv) the measurement of operating lease liabilities, and (v) the evaluation of the recoverability of long-lived assets, including intangible assets. On an ongoing basis, the Company evaluates these judgments and estimates for reasonableness.

Fair Value Measurements

Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or

permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability.

The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:

Level 1    Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2    Inputs other than the quoted prices in active markets that are observable either directly or indirectly.

Level 3    Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions.

Certain of the Company’s financial instruments, including cash and cash equivalents, accounts payable, accrued expenses and other current liabilities are carried at cost, which approximates their fair value because of their short-term nature. The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis:

(in thousands)

Level 1

    

Level 2

    

Level 3

    

Total

June 30, 2025

Current Assets

Cash equivalents in money market funds (Note 5)

$

6,447

$

$

$

6,447

U.S. treasury securities

215,865

215,865

Equity securities(1)

1,258

1,258

Total current assets at fair value

$

223,570

$

$

$

223,570

Liabilities

Sponsor Earn-Out liabilities

$

$

$

3,036

$

3,036

Total liabilities at fair value

$

$

$

3,036

$

3,036

December 31, 2024

Current Assets

Cash equivalents in money market funds (Note 5)

$

120,888

$

$

$

120,888

U.S. treasury securities

132,782

132,782

Equity securities(1)

967

967

Total current assets at fair value

$

254,637

$

$

$

254,637

Liabilities

Sponsor Earn-Out liabilities

$

$

$

9,472

$

9,472

Total liabilities at fair value

$

$

$

9,472

$

9,472

(1) Fair value was determined using publicly quoted market prices obtained from third-party sources in their respective markets.

 

There were no transfers in or out of Level 3 measurements during the three and six months ended June 30, 2025 and 2024.

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-9, Improvements to Income Tax Disclosures, which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. We are currently evaluating the impact this ASU will have when adopted and anticipate this ASU will likely result in the required additional disclosures being included in our consolidated financial statements.

In November 2024, The FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which requires more detailed information about the types of expenses included in certain expense captions presented on the consolidated statements of operations. Additionally, this amendment requires the disclosure of a qualitative description of the amounts remaining in relevant expense captions that

are not separately disaggregated quantitatively and the disclosure of the total amount of selling expenses. The new standard is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact of adoption on our consolidated financial statements.

The Company has reviewed all accounting pronouncements issued during the three months ended June 30, 2025 and concluded that they were either not applicable or not expected to have a material impact on the Company’s condensed consolidated financial statements.

 

 

 

v3.25.2
Revenue
6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue

Note 3.  Revenue

We disaggregate our revenue from customers by the type of arrangement, primarily from the sale of battery products and from providing research and development services, as this depicts how the nature, amount, timing, and cash flows are affected by economic factors. The following table summarizes the Company’s disaggregated revenue:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Revenue from customers:

Service revenue

$

3,527

$

$

9,311

$

Product revenue

9

Total revenue from customers

$

3,527

$

$

9,320

$

Remaining Performance Obligations

We have performance obligations associated with commitments in customer contracts for future services that have not yet been recognized as revenue. As of June 30, 2025, the aggregate amount of the transaction price allocated to the remaining performance obligations related to customer contracts that were unsatisfied or partially unsatisfied, was $3.7 million, which is expected to be recognized as revenue within the next twelve months. This amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations is subject to change and is affected by changes to scope, changes in timing of delivery of products and services, or contract modifications.

v3.25.2
Partnerships
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Partnerships

Note 4.  Partnerships

In March 2024, the Company extended a joint development agreement (“JDA”) with Hyundai Motor Company (“Hyundai”) to jointly research and develop B-sample Li-Metal battery technology, until December 2025. Under the terms of the JDA, the Company will fund the research and development activities, and the capital expenditures related to the buildout of pilot manufacturing lines.

The Company’s B-Sample JDA with Honda Motor Company, Ltd. (“Honda”) has been replaced with a B-sample services agreement in January 2025, with a term through the end of 2025.

The Company’s partnership with GM Global Technology Operations LLC (“GM Technology”), an affiliate of GM Ventures LLC (“GM Ventures”), and General Motors Holdings LLC (“GM Holdings”) (collectively, “General Motors” or “GM”) to jointly research and develop the A-Sample Li-Metal batteries concluded in September 2024.

The following table summarizes credits to research and development recorded in accordance with the terms of the JDA agreements:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

    

2024

    

2025

    

2024

Research and development (related party)

$

$

$

$

1,217

Research and development (non-related party)

577

2,885

Total reimbursements to research and development

$

$

577

$

$

4,102

 

v3.25.2
Cash and Cash Equivalents
6 Months Ended
Jun. 30, 2025
Cash and Cash Equivalents [Abstract]  
Cash and Cash Equivalents

Note 5.  Cash and Cash Equivalents

Cash, cash equivalents, and restricted cash consisted of the following:

(in thousands)

June 30, 2025

    

December 31, 2024

Cash

$

5,310

$

7,908

Money market funds

 

6,447

 

120,888

Total cash and cash equivalents

11,757

128,796

Restricted cash included in other assets

 

651

 

599

Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows

$

12,408

$

129,395

 

 

Restricted cash includes cash held in checking and money market funds as collateral to secure certain insurance policies and a letter of credit for corporate lease activity. 

v3.25.2
Short-Term Investments
6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Short-Term Investments

Note 6.  Short-Term Investments

Marketable Securities

The following table provides amortized costs, gross unrealized gains and losses, and fair values for the Company’s investments in available-for-sale U.S. treasury securities as of June 30, 2025 and December 31, 2024, which have maturity dates that range from 0 month to 10 months, respectively. Fair value was determined using market prices obtained from third-party sources. Realized gains or losses were insignificant for the three and six months ended June 30, 2025 and 2024.

June 30, 2025

Gross

Gross

(in thousands)

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

U.S. treasury securities

$

215,772

$

133

$

(40)

$

215,865

Total short-term marketable securities

$

215,772

$

133

$

(40)

$

215,865

December 31, 2024

Gross

Gross

(in thousands)

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

U.S. treasury securities

$

132,615

$

167

$

$

132,782

Total short-term marketable securities

$

132,615

$

167

$

$

132,782

 

 

The Company has $1.3 million and $1.0 million marketable equity securities as of June 30, 2025 and December 31, 2024, respectively, with an initial cost of $0.5 million. Total unrealized gain of $0.8 million and $0.5 million is recorded under miscellaneous (expense) income, net in the consolidated statements of operations and comprehensive loss for the periods ended June 30, 2025 and December 31, 2024, respectively.

 

v3.25.2
Accrued Expenses and Other Current Liabilities
6 Months Ended
Jun. 30, 2025
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities

Note 7.  Accrued Expenses and Other Current Liabilities

The components of accrued expenses and other current liabilities consisted of the following:

(in thousands)

June 30, 2025

    

December 31, 2024

Vendor project charges

$

5,956

$

7,500

Employee compensation and related costs

4,048

6,646

Income taxes payable

1,049

313

Professional and consulting services

871

1,480

Deferred income

862

Software services

837

Construction in process

339

1,408

Other

 

826

 

982

Accrued expenses and other current liabilities

$

14,788

$

18,329

 

 

 

v3.25.2
Government Grant
6 Months Ended
Jun. 30, 2025
Government Assistance [Abstract]  
Government Grant

Note 8.  Government Grant

In December 2022, the Company was awarded a grant (the “Grant”) from certain Korean government agencies. The incentives received under the Grant, which is in the form of cash, can be used for facilities related expenses and the purchase of property and equipment. The Company is required to adhere to the following conditions attached to the incentives, which include purchase of a government grant guarantee insurance policy, required minimum investments into specified spending categories and the creation of a minimum amount of permanent full-time jobs in a certain geographical location over the next five years, with the option to extend to 10 years by remaining in a certain geographical location. If determined that we were ineligible to receive the Grant, we could be required to repay the Grant in entirety

with interest. The Company has yet to fulfill the required minimum investment and minimum employment conditions hence interest payable was recorded. Compliance with these conditions will continue to be monitored over the remaining grant period.

As of June 30, 2025 and December 31, 2024, the Company has received, but not yet earned, cash grants of 12.0 billion Korean won. These balances are equivalent to $8.9 million and $8.1 million, after translation, respectively, as of June 30, 2025 and December 31, 2024, which is disclosed as unearned government grant in the condensed consolidated balance sheets.

v3.25.2
Sponsor Earn-Out Liabilities
6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Sponsor Earn-Out Liabilities

Note 9.  Sponsor Earn-Out Liabilities

The Sponsor Earn-Out shares in Tranche 2 through Tranche 5 have been measured at their estimated fair value using a Monte Carlo simulation valuation model. Inherent in the valuation model are assumptions related to expected stock price volatility, risk-free interest rate, expected term, and dividend yield. The key inputs used in the Monte Carlo simulation model at their respective measurement dates were as follows:

June 30, 2025

December 31, 2024

Expected term (in years)

5.5

5.9

Risk free rate

3.80%

4.38%

Expected volatility

100.0%

95.0%

Expected dividends

0%

0%

Stock price

$

0.89

$

2.19

 

The stock price is based on the closing price of the Company’s Class A common stock as of the valuation date and simulated through the end of the earn-out period following Geometric Brownian Motion. The Company estimates the volatility of its common stock by using a weighted average of historical volatilities of SES’s shares and warrants and select peer companies’ common stock that matches the expected term of the awards (range of the weighted average of volatility was 87.9% - 101.6% and 87.3% - 122.5% as of June 30, 2025 and December 31, 2024, respectively). The expected term is derived from a probability weighted model, considering a number of inputs, including the probability of a change in control. The risk-free interest rate is based on the yield curve for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides a reconciliation of the beginning and ending balances for the Sponsor Earn-Out liabilities:

(in thousands)

Balance as of December 31, 2024

$

9,472

Change in fair value

  

(6,436)

Balance as of June 30, 2025

$

3,036

Balance as of December 31, 2023

$

4,166

Change in fair value

(2,286)

Balance as of June 30, 2024

$

1,880

 

 

 

v3.25.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 10.  Commitments and Contingencies

Commitments

Under the terms of one of the JDAs entered into in 2021 and amended in March 2024, the Company is committed to undertake certain research and development activities for the benefit of both itself and its OEM Partner which involve expenditures related to engineering efforts and purchases of related equipment. The Company has a remaining commitment to spend up to $9.9 million under this JDA as of June 30, 2025.

In December 2021, the Company amended the lease agreement for an office space in Woburn, Massachusetts. The amendment includes an obligation for the Company to pay monthly relinquishment charges (equal to the total rental obligation for the duration of the lease term) only if the new tenant does not pay the monthly rental amount and the lessor has provided a notice to collect the relinquishment charges from the Company. As of June 30, 2025, the Company assessed the probability of any liability to be incurred for relinquishment charges as remote.

Legal Contingencies

From time-to-time, the Company may be subject to claims arising in the ordinary course of business or become involved in litigation or other legal proceedings. While the outcome of such claims or other proceedings cannot be predicted with certainty, the Company’s management expects that any such liabilities, to the extent not provided for by insurance or otherwise, would not have a material effect on the Company’s financial condition, results of operations or cash flows.

Indemnifications

The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, partnerships, landlords, vendors, and contractors. Pursuant to these arrangements, the Company agrees to indemnify, defend, and hold harmless the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company’s activities. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification provisions. In addition, the Company indemnifies its officers, directors, and certain key employees against claims made with respect to matters that arise while they are serving in their respective capacities as such, subject to certain limitations set forth under applicable law, and applicable indemnification agreements. The Company maintains insurance, including commercial general liability insurance, product liability insurance, and directors and officers insurance to offset certain potential liabilities under these indemnification provisions. To date, there have been no claims under these indemnification provisions.

v3.25.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 11.  Stock-Based Compensation

The Company’s stock-based compensation included in its condensed consolidated statements of operations and comprehensive loss, net of forfeitures, was as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

    

2024

    

2025

    

2024

Research and development

$

691

$

1,616

$

1,841

$

3,067

General and administrative

 

1,911

 

3,186

 

4,573

 

6,519

Cost of revenue

 

93

 

254

Total stock-based compensation

$

2,695

$

4,802

$

6,668

$

9,586

 

The following table summarizes stock-based compensation expense by award type, net of forfeitures:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Restricted Stock Units ("RSUs")

$

1,956

$

3,604

$

4,771

$

6,689

Performance Stock Units ("PSUs")

256

700

913

1,632

Restricted Stock Awards ("RSAs")

474

487

952

978

Stock options

9

11

32

287

Total

$

2,695

$

4,802

$

6,668

$

9,586

PSUs are measured at their estimated fair value using a Monte Carlo simulation valuation model with the effect of the market condition reflected in the grant date fair value of the award. The fair value of RSUs is estimated based on the closing price of the Company’s Class A common stock at the date of grant.

 

v3.25.2
Income Taxes
6 Months Ended
Jun. 30, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

Note 12.   Income Taxes

The Company’s effective tax rate for the three and six months ended June 30, 2025 was (3.4)% and (2.1)%, respectively, compared with (0.4)% and (0.80)% for the three and six months ended June 30, 2024. The difference between the provision for income taxes and the income tax determined by applying the statutory federal income tax rate of 21% principally results from income taxes on earnings from its foreign tax jurisdictions offset by losses generated in the U.S. where no benefit was recorded because the Company had fully reserved its deferred tax assets as of June 30, 2025 and December 31, 2024 and the recording of uncertain tax positions and interest expense.

v3.25.2
Net Loss Per Share
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Net Loss Per Share

Note 13.  Net Loss Per Share

Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss, as adjusted for changes in fair value recognized in earnings from equity contracts classified as liabilities, by the weighted average number of common shares outstanding and, when dilutive, common share equivalents from outstanding stock options and restricted stock units (using the treasury-stock method). The weighted-average number of common shares used in the computation of basic and diluted net loss per share were as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands, except share and per share amounts)

2025

   

2024

   

2025

   

2024

Numerator:

  

  

  

  

Net loss attributable to common stockholders - basic

$

(22,651)

$

(19,897)

$

(35,083)

$

(35,454)

Denominator:

Weighted average shares of common stock outstanding - basic and diluted

331,731,923

 

320,833,854

 

330,539,801

 

319,812,287

Net loss per share attributable to common stockholders - basic and diluted

$

(0.07)

$

(0.06)

$

(0.11)

$

(0.11)

 

The number of common stock equivalents excluded from the computation of diluted net loss per share because either the effect would have been anti-dilutive, or the performance criteria related to such shares and awards had not been met, were as follows:

As of June 30, 

2025

2024

Escrowed earn-out shares

27,690,978

27,690,978

Options to purchase common stock

5,922,855

11,634,356

Public warrants

9,199,947

9,199,947

Sponsor Earn-Out Shares

5,520,000

5,520,000

Private warrants

5,013,333

5,013,333

Unvested RSUs

14,236,250

14,687,464

Unvested PSUs

5,784,050

6,159,793

Earn-out Restricted Shares

742,399

831,171

Unvested RSAs

63,749

454,561

Total

74,173,561

81,191,603

 

 

 

 

 

v3.25.2
Segment and Geographic Information
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Segment and Geographic Information

14. Segment and Geographic Information

Operating Segments

Operating segments are defined as components of an entity for which separate financial information is available and that is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources to an individual segment and in assessing performance. The Company’s CODM is its Chief Executive Officer. The Company has determined that it operates in one operating and reportable segment, as the CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM uses operating income (loss) as the measure of financial performance and for resource allocation decisions.

Significant Expenses

The Company concluded it operates as one operating and reportable segment based on the information regularly reviewed by the CODM for decision making, resource allocation, and evaluating financial performance. The information included is categorized into different significant expense lines such as compensation and benefits, lab and equipment, professional services, general and administrative, facility, and sales and marketing. The Company reported the following significant expenses to the CODM:

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Compensation and benefits

$

7,930

$

9,844

$

14,299

$

16,957

Stock compensation

2,797

4,802

6,728

9,586

Lab and equipment

3,074

1,757

8,883

3,087

General and administrative

4,091

2,718

7,993

7,548

Professional services

6,080

2,233

12,165

4,252

Facility

1,444

2,998

2,991

4,026

Marketing and sales

191

275

378

442

$

25,607

$

24,627

$

53,437

$

45,898

Geographic Information

For the three and six months ended June 30 2025, revenue outside of the United States, based on customer billing address in the Asia Pacific region, was 100% of total revenue.

v3.25.2
Related-Party Transactions
6 Months Ended
Jun. 30, 2025
Related Party Transactions [Abstract]  
Related-Party Transactions

Note 15.  Related-Party Transactions

Pursuant to the director nomination agreement, dated as of July 12, 2021, with the Company (the “Director Nomination Agreement”), General Motors Company and its affiliates (“GM”) were considered related parties due to their board representation and the board member’s employment position at GM, which remained in effect as long as GM continues to hold more than 5% of the fully diluted outstanding equity securities of SES as per the agreement. On October 29, 2024, GM and the Company mutually agreed to terminate the Director Nomination Agreement and GM terminated its board representation. Hence, GM is no longer considered a related party during 2025. See “Note 4 – Partnerships” for more details about our prior partnership with GM.

v3.25.2
Subsequent Events
6 Months Ended
Jun. 30, 2025
Subsequent Events [Abstract]  
Subsequent Events

Note 16.  Subsequent Events

Acquisition of Shenzhen UZ Energy Co., Ltd. (“UZ Energy”)

On July 25, 2025, our wholly-owned subsidiary, SES AI International I Pte Ltd, entered into an agreement with UZ Energy and its shareholders to acquire 100% of the share capital of UZ Energy, a China-based battery energy storage system manufacturer. The total estimated purchase consideration for the acquisition of UZ Energy is approximately RMB 183,460,000 ($25,480,556), subject to adjustment based on a number of performance factors. Approximately RMB 90,000,000 ($12,500,000) of the consideration will be in the form of a subscription for new shares of UZ Energy, while the balance of consideration will be paid to UZ Energy’s existing shareholders for the acquisition of their shares. The transaction is expected to close in the third quarter of 2025 and is subject to customary closing conditions.

Enactment of the “One Big Beautiful Bill Act” (OBBBA)

On July 4, 2025, tax legislation known as the One Big Beautiful Bill Act ("OBBBA") was enacted in the United States. Key corporate tax provisions include the restoration of 100% bonus depreciation, immediate expensing for domestic research and experimental expenditures, changes to Section 163(j) interest limitations, updates to Global Intangible Low-Taxed Income (“GILTI”) and Foreign-Derived Intangible Income (“FDII”) rules, amendments to energy credits, and expanded Section 162(m) aggregation requirements. In accordance with ASC 740, the effects of the new tax law will be recognized in the period of enactment. The Company is currently evaluating the impact of the OBBBA, and an estimate of the financial effect is not yet available. Due to the timing of enactment, the Company plans to recognize any such impact on the Company's Form 10-Q filed for the period ending September 30, 2025.

v3.25.2
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Pay vs Performance Disclosure            
Net Income (Loss) $ (22,651) $ (12,432) $ (19,897) $ (15,557) $ (35,083) $ (35,454)
v3.25.2
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements include the accounts of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and regulations of the U.S. Securities and Exchange Commission (“SEC”) for interim financial reporting. Management believes that all adjustments necessary for the fair presentation of results, consisting of normally recurring items, have been included in the condensed consolidated financial statements for the interim periods presented. The results of operations for the three and six months ended June 30, 2025 are not necessarily indicative of the results that may be expected for the full year or any other future interim or annual periods. All intercompany balances and transactions have been eliminated in consolidation. The Company’s fiscal year ends on December 31.

The year-end balance sheet data was derived from audited consolidated financial statements. These unaudited interim condensed consolidated financial statements do not include all of the annual disclosures required by U.S. GAAP; accordingly, they should be read in conjunction with the audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2025, as amended on April 30, 2025 (the “2024 Annual Report on Form 10-K”).

Use of estimates

Use of estimates

The preparation of these condensed consolidated financial statements in conformity with U.S. GAAP requires management to make use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of commitments and contingencies, and the reported amounts of revenues, if any, and expenses. The Company bases its estimates on available historical experience and on various other factors that the Company believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not apparent from other sources. Changes in estimates are reflected in reported results for the period in which they become known. Actual results may differ from those estimates.

Significant estimates and assumptions include those related to the valuation of (i) certain equity awards, including common stock awards prior to the Business Combination, the Sponsor Earn-Out Shares, the Earn-Out Restricted Shares, and performance stock units, (ii) revenue from customers, (iii) deferred tax assets and uncertain income tax positions, (iv) the measurement of operating lease liabilities, and (v) the evaluation of the recoverability of long-lived assets, including intangible assets. On an ongoing basis, the Company evaluates these judgments and estimates for reasonableness.

Fair Value Measurements

Fair Value Measurements

Fair value is defined as an exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or

permitted to be either recorded or disclosed at fair value, the Company considers the principal or most advantageous market in which it would transact, and it also considers assumptions that market participants would use when pricing the asset or liability.

The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. GAAP establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is as follows:

Level 1    Observable inputs such as quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2    Inputs other than the quoted prices in active markets that are observable either directly or indirectly.

Level 3    Unobservable inputs in which there are little or no market data and which require the Company to develop its own assumptions.

Certain of the Company’s financial instruments, including cash and cash equivalents, accounts payable, accrued expenses and other current liabilities are carried at cost, which approximates their fair value because of their short-term nature. The following table presents information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis:

(in thousands)

Level 1

    

Level 2

    

Level 3

    

Total

June 30, 2025

Current Assets

Cash equivalents in money market funds (Note 5)

$

6,447

$

$

$

6,447

U.S. treasury securities

215,865

215,865

Equity securities(1)

1,258

1,258

Total current assets at fair value

$

223,570

$

$

$

223,570

Liabilities

Sponsor Earn-Out liabilities

$

$

$

3,036

$

3,036

Total liabilities at fair value

$

$

$

3,036

$

3,036

December 31, 2024

Current Assets

Cash equivalents in money market funds (Note 5)

$

120,888

$

$

$

120,888

U.S. treasury securities

132,782

132,782

Equity securities(1)

967

967

Total current assets at fair value

$

254,637

$

$

$

254,637

Liabilities

Sponsor Earn-Out liabilities

$

$

$

9,472

$

9,472

Total liabilities at fair value

$

$

$

9,472

$

9,472

(1) Fair value was determined using publicly quoted market prices obtained from third-party sources in their respective markets.

 

There were no transfers in or out of Level 3 measurements during the three and six months ended June 30, 2025 and 2024.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-9, Improvements to Income Tax Disclosures, which requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. We are currently evaluating the impact this ASU will have when adopted and anticipate this ASU will likely result in the required additional disclosures being included in our consolidated financial statements.

In November 2024, The FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses, which requires more detailed information about the types of expenses included in certain expense captions presented on the consolidated statements of operations. Additionally, this amendment requires the disclosure of a qualitative description of the amounts remaining in relevant expense captions that

are not separately disaggregated quantitatively and the disclosure of the total amount of selling expenses. The new standard is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. We are currently evaluating the impact of adoption on our consolidated financial statements.

The Company has reviewed all accounting pronouncements issued during the three months ended June 30, 2025 and concluded that they were either not applicable or not expected to have a material impact on the Company’s condensed consolidated financial statements.

v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2025
Accounting Policies [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis

(in thousands)

Level 1

    

Level 2

    

Level 3

    

Total

June 30, 2025

Current Assets

Cash equivalents in money market funds (Note 5)

$

6,447

$

$

$

6,447

U.S. treasury securities

215,865

215,865

Equity securities(1)

1,258

1,258

Total current assets at fair value

$

223,570

$

$

$

223,570

Liabilities

Sponsor Earn-Out liabilities

$

$

$

3,036

$

3,036

Total liabilities at fair value

$

$

$

3,036

$

3,036

December 31, 2024

Current Assets

Cash equivalents in money market funds (Note 5)

$

120,888

$

$

$

120,888

U.S. treasury securities

132,782

132,782

Equity securities(1)

967

967

Total current assets at fair value

$

254,637

$

$

$

254,637

Liabilities

Sponsor Earn-Out liabilities

$

$

$

9,472

$

9,472

Total liabilities at fair value

$

$

$

9,472

$

9,472

(1) Fair value was determined using publicly quoted market prices obtained from third-party sources in their respective markets.

v3.25.2
Revenue (Tables)
6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of company's disaggregated revenue

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Revenue from customers:

Service revenue

$

3,527

$

$

9,311

$

Product revenue

9

Total revenue from customers

$

3,527

$

$

9,320

$

v3.25.2
Partnerships (Tables)
6 Months Ended
Jun. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of expenses incurred that were recorded as a credit to research and development expense in the consolidated statement of operations and comprehensive loss

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

    

2024

    

2025

    

2024

Research and development (related party)

$

$

$

$

1,217

Research and development (non-related party)

577

2,885

Total reimbursements to research and development

$

$

577

$

$

4,102

 

v3.25.2
Cash and Cash Equivalents (Tables)
6 Months Ended
Jun. 30, 2025
Cash and Cash Equivalents [Abstract]  
Schedule of cash, cash equivalents, and restricted cash

(in thousands)

June 30, 2025

    

December 31, 2024

Cash

$

5,310

$

7,908

Money market funds

 

6,447

 

120,888

Total cash and cash equivalents

11,757

128,796

Restricted cash included in other assets

 

651

 

599

Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows

$

12,408

$

129,395

 

v3.25.2
Short-Term Investments (Tables)
6 Months Ended
Jun. 30, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of amortized costs, gross unrealized gains and losses, and fair values of investments

June 30, 2025

Gross

Gross

(in thousands)

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

U.S. treasury securities

$

215,772

$

133

$

(40)

$

215,865

Total short-term marketable securities

$

215,772

$

133

$

(40)

$

215,865

December 31, 2024

Gross

Gross

(in thousands)

Amortized Cost

    

Unrealized Gains

    

Unrealized Losses

    

Fair Value

U.S. treasury securities

$

132,615

$

167

$

$

132,782

Total short-term marketable securities

$

132,615

$

167

$

$

132,782

 

v3.25.2
Accrued Expenses and Other Current Liabilities (Tables)
6 Months Ended
Jun. 30, 2025
Payables and Accruals [Abstract]  
Schedule of accrued expenses and other current liabilities

(in thousands)

June 30, 2025

    

December 31, 2024

Vendor project charges

$

5,956

$

7,500

Employee compensation and related costs

4,048

6,646

Income taxes payable

1,049

313

Professional and consulting services

871

1,480

Deferred income

862

Software services

837

Construction in process

339

1,408

Other

 

826

 

982

Accrued expenses and other current liabilities

$

14,788

$

18,329

 

v3.25.2
Sponsor Earn-Out Liabilities (Tables)
6 Months Ended
Jun. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of key inputs into the Monte Carlo simulation model for the Sponsor Earn-Out liability

June 30, 2025

December 31, 2024

Expected term (in years)

5.5

5.9

Risk free rate

3.80%

4.38%

Expected volatility

100.0%

95.0%

Expected dividends

0%

0%

Stock price

$

0.89

$

2.19

 

Schedule of the reconciliation of the Sponsor Earn-Out liability

(in thousands)

Balance as of December 31, 2024

$

9,472

Change in fair value

  

(6,436)

Balance as of June 30, 2025

$

3,036

Balance as of December 31, 2023

$

4,166

Change in fair value

(2,286)

Balance as of June 30, 2024

$

1,880

 

v3.25.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation included in its condensed consolidated statements of operations and comprehensive income (loss)

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

    

2024

    

2025

    

2024

Research and development

$

691

$

1,616

$

1,841

$

3,067

General and administrative

 

1,911

 

3,186

 

4,573

 

6,519

Cost of revenue

 

93

 

254

Total stock-based compensation

$

2,695

$

4,802

$

6,668

$

9,586

 

Schedule of share-based compensation expense by award type

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Restricted Stock Units ("RSUs")

$

1,956

$

3,604

$

4,771

$

6,689

Performance Stock Units ("PSUs")

256

700

913

1,632

Restricted Stock Awards ("RSAs")

474

487

952

978

Stock options

9

11

32

287

Total

$

2,695

$

4,802

$

6,668

$

9,586

v3.25.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted net loss per share

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands, except share and per share amounts)

2025

   

2024

   

2025

   

2024

Numerator:

  

  

  

  

Net loss attributable to common stockholders - basic

$

(22,651)

$

(19,897)

$

(35,083)

$

(35,454)

Denominator:

Weighted average shares of common stock outstanding - basic and diluted

331,731,923

 

320,833,854

 

330,539,801

 

319,812,287

Net loss per share attributable to common stockholders - basic and diluted

$

(0.07)

$

(0.06)

$

(0.11)

$

(0.11)

 

Schedule of potentially anti-dilutive securities

As of June 30, 

2025

2024

Escrowed earn-out shares

27,690,978

27,690,978

Options to purchase common stock

5,922,855

11,634,356

Public warrants

9,199,947

9,199,947

Sponsor Earn-Out Shares

5,520,000

5,520,000

Private warrants

5,013,333

5,013,333

Unvested RSUs

14,236,250

14,687,464

Unvested PSUs

5,784,050

6,159,793

Earn-out Restricted Shares

742,399

831,171

Unvested RSAs

63,749

454,561

Total

74,173,561

81,191,603

 

v3.25.2
Segment and Geographic Information (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of significant expenses to the CODM

Three Months Ended June 30, 

Six Months Ended June 30, 

(in thousands)

2025

2024

2025

2024

Compensation and benefits

$

7,930

$

9,844

$

14,299

$

16,957

Stock compensation

2,797

4,802

6,728

9,586

Lab and equipment

3,074

1,757

8,883

3,087

General and administrative

4,091

2,718

7,993

7,548

Professional services

6,080

2,233

12,165

4,252

Facility

1,444

2,998

2,991

4,026

Marketing and sales

191

275

378

442

$

25,607

$

24,627

$

53,437

$

45,898

v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies - Fair Value - Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Assets, Fair Value Disclosure [Abstract]    
Debt securities, available-for-sale $ 215,865 $ 132,782
Equity securities $ 1,300 $ 1,000
Financial Liabilities Fair Value Disclosure [Abstract]    
Derivative Liability, Statement of Financial Position Sponsor Earn-Out liabilities Sponsor Earn-Out liabilities
Fair Value, Recurring    
Assets, Fair Value Disclosure [Abstract]    
Debt securities, available-for-sale $ 215,865 $ 132,782
Equity securities 1,258 967
Assets 223,570 254,637
Financial Liabilities Fair Value Disclosure [Abstract]    
Sponsor Earn-Out liabilities 3,036 9,472
Total liabilities at fair value 3,036 9,472
Fair Value, Recurring | Money Market Funds    
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents 6,447 120,888
Fair Value, Recurring | Fair Value, Inputs, Level 1    
Assets, Fair Value Disclosure [Abstract]    
Debt securities, available-for-sale 215,865 132,782
Equity securities 1,258 967
Assets 223,570 254,637
Fair Value, Recurring | Fair Value, Inputs, Level 1 | Money Market Funds    
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents 6,447 120,888
Fair Value, Recurring | Fair Value, Inputs, Level 3    
Financial Liabilities Fair Value Disclosure [Abstract]    
Sponsor Earn-Out liabilities 3,036 9,472
Total liabilities at fair value $ 3,036 $ 9,472
v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies - Fair Value - Transfers (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net [Abstract]        
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, transfers, net $ 0 $ 0 $ 0 $ 0
v3.25.2
Basis of Presentation and Summary of Significant Accounting Policies - Recently Issued Accounting Pronouncements (Details)
Jun. 30, 2025
Accounting Standards Update 2023-09  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Change in Accounting Principle, Accounting Standards Update, Adopted false
v3.25.2
Revenue (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Revenue from customers:    
Total revenue from customers $ 3,527 $ 9,320
Revenue remaining performance obligation $ 3,700 $ 3,700
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-07-01    
Revenue from customers:    
Expected period of revenue recognition 12 months 12 months
Service revenue    
Revenue from customers:    
Total revenue from customers $ 3,527 $ 9,311
Product revenue    
Revenue from customers:    
Total revenue from customers   $ 9
v3.25.2
Partnerships (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Research and development (related party)   $ 1,217
Research and development (non-related party) $ 577 2,885
Total reimbursements to research and development $ 577 $ 4,102
v3.25.2
Cash and Cash Equivalents (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Jun. 30, 2024
Dec. 31, 2023
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]        
Cash $ 5,310 $ 7,908    
Money market funds 6,447 120,888    
Total cash and cash equivalents 11,757 128,796    
Restricted cash included in other assets $ 651 $ 599    
Restricted Cash and Cash Equivalents, Noncurrent, Statement of Financial Position Other assets, non-current Other assets, non-current    
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows $ 12,408 $ 129,395 $ 56,069 $ 86,966
v3.25.2
Short-Term Investments - General Information (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Available-for-Sale [Abstract]    
Equity securities with an initial cost $ 0.5  
Equity securities unrealized gain (loss) $ 0.8 $ 0.5
Minimum    
Debt Securities, Available-for-Sale [Abstract]    
Debt securities, available-for-sale, term 0 months 0 months
Maximum    
Debt Securities, Available-for-Sale [Abstract]    
Debt securities, available-for-sale, term 10 months 10 months
v3.25.2
Short-Term Investments - Tabular Disclosure (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]    
Debt securities, available-for-sale, current $ 217,123 $ 133,748
Amortized cost 215,772 132,615
Gross unrealized gains 133 167
Gross unrealized losses (40)  
Fair value 215,865 132,782
US Treasury Securities    
Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]    
Amortized cost, current 215,772 132,615
Gross unrealized gains, current 133 167
Gross unrealized losses, current (40)  
Debt securities, available-for-sale, current $ 215,865 $ 132,782
v3.25.2
Short-Term Investments - Equity Securities (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Equity Securities, FV-NI [Abstract]    
Equity securities $ 1.3 $ 1.0
Debt Securities, Trading, and Equity Securities, FV-NI, Cost [Abstract]    
Equity securities with an initial cost 0.5  
Equity Securities, FV-NI, Unrealized Gain (Loss) [Abstract]    
Equity securities unrealized gain (loss) $ 0.8 $ 0.5
v3.25.2
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Vendor project charges $ 5,956 $ 7,500
Employee compensation and related costs 4,048 6,646
Income taxes payable 1,049 313
Professional and consulting services 871 1,480
Deferred income 862  
Software services 837  
Construction in process 339 1,408
Other 826 982
Accrued expenses and other current liabilities $ 14,788 $ 18,329
v3.25.2
Government Grant (Details)
$ in Millions, ₩ in Billions
1 Months Ended
Dec. 31, 2022
Jun. 30, 2025
KRW (₩)
Jun. 30, 2025
USD ($)
Dec. 31, 2024
KRW (₩)
Dec. 31, 2024
USD ($)
Government Grant          
Government assistance, transaction duration 5 years        
Unearned government grant, excluding accrued interest   ₩ 12.0 $ 8.9 ₩ 12.0 $ 8.1
Maximum          
Government Grant          
Government assistance, transaction duration 10 years        
v3.25.2
Sponsor Earn-Out Liabilities - Key Inputs (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Y
$ / shares
Dec. 31, 2024
Y
$ / shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Derivative Liability, Valuation Technique us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:ValuationTechniqueOptionPricingModelMember
Sponsor earn-out liability, price volatility, weighted-average, low end of range (as a percent) 87.90% 87.30%
Sponsor earn-out liability, price volatility, weighted-average, high end of range (as a percent) 101.60% 122.50%
Measurement Input, Expected Term    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Sponsor earn-out liability, measurement input | Y 5.5 5.9
Measurement Input, Risk Free Interest Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Sponsor earn-out liability, measurement input 0.038 0.0438
Measurement Input, Price Volatility    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Sponsor earn-out liability, measurement input 1 0.95
Measurement Input, Expected Dividend Rate    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Sponsor earn-out liability, measurement input 0 0
Measurement Input, Share Price    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Sponsor earn-out liability, measurement input | $ / shares 0.89 2.19
v3.25.2
Sponsor Earn-Out Liabilities - Reconciliation (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Beginning Balance $ 9,472 $ 4,166
Change in fair value (6,436) (2,286)
Ending Balance $ 3,036 $ 1,880
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income (Loss) Gain on change in fair value of Sponsor Earn-Out liabilities (Loss) Gain on change in fair value of Sponsor Earn-Out liabilities
v3.25.2
Commitments and Contingencies (Details)
$ in Millions
Jun. 30, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
The Company has a remaining commitment to spend $ 9.9
v3.25.2
Stock-Based Compensation - Stock-based Compensation Expense - Statement of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Stock-Based Compensation        
Total stock-based compensation $ 2,695 $ 4,802 $ 6,668 $ 9,586
Research and development        
Stock-Based Compensation        
Total stock-based compensation 691 1,616 1,841 3,067
General and administrative        
Stock-Based Compensation        
Total stock-based compensation 1,911 $ 3,186 4,573 $ 6,519
Cost of revenue        
Stock-Based Compensation        
Total stock-based compensation $ 93   $ 254  
v3.25.2
Stock-Based Compensation - Stock-based Compensation Expense - Award Type (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Stock-Based Compensation        
Total stock-based compensation $ 2,695 $ 4,802 $ 6,668 $ 9,586
Restricted Stock Units ("RSUs")        
Stock-Based Compensation        
Total stock-based compensation 1,956 3,604 4,771 6,689
Performance Stock Units ("PSUs")        
Stock-Based Compensation        
Total stock-based compensation 256 700 913 1,632
Restricted Stock Awards ("RSAs")        
Stock-Based Compensation        
Total stock-based compensation 474 487 952 978
Employee Stock Option        
Stock-Based Compensation        
Total stock-based compensation $ 9 $ 11 $ 32 $ 287
v3.25.2
Income Taxes (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Effective Income Tax Rate Reconciliation, Percent [Abstract]        
Effective tax rate (as a percent) (3.40%) (0.40%) (2.10%) (0.80%)
Statutory federal income tax rate (as a percent) 21.00% 21.00% 21.00% 21.00%
v3.25.2
Net Loss Per Share - Basic and Diluted Loss Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]        
Net loss attributable to common stockholders - basic $ (22,651) $ (19,897) $ (35,083) $ (35,454)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]        
Weighted average shares of common stock outstanding - basic (in shares) 331,731,923 320,833,854 330,539,801 319,812,287
Weighted average shares of common stock outstanding - diluted (in shares) 331,731,923 320,833,854 330,539,801 319,812,287
Earnings Per Share, Diluted [Abstract]        
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (0.07) $ (0.06) $ (0.11) $ (0.11)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (0.07) $ (0.06) $ (0.11) $ (0.11)
v3.25.2
Net Loss Per Share - Potentially Dilutive Securities (Details) - shares
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 74,173,561 81,191,603
Escrowed earn-out shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 27,690,978 27,690,978
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,922,855 11,634,356
Public warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 9,199,947 9,199,947
Sponsor Earn-Out Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,520,000 5,520,000
Private warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,013,333 5,013,333
Unvested RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 14,236,250 14,687,464
Unvested PSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 5,784,050 6,159,793
Earn-out Restricted Shares    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 742,399 831,171
Unvested RSAs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 63,749 454,561
v3.25.2
Segment and Geographic Information - Segment Information (Details) - segment
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting, Disclosure of Entity's Reportable Segments [Abstract]        
Number of operating segments 1 1 1 1
Number of reportable segments 1 1 1 1
Segment Reporting, CODM, Individual Title and Position or Group Name srt:ChiefExecutiveOfficerMember srt:ChiefExecutiveOfficerMember srt:ChiefExecutiveOfficerMember srt:ChiefExecutiveOfficerMember
v3.25.2
Segment and Geographic Information - Significant Expenses (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information, Profit (Loss) [Abstract]        
Stock compensation     $ 6,686 $ 9,586
General and administrative $ 6,520 $ 9,570 13,840 19,076
Total operating expenses 25,607 24,627 53,437 45,898
Single Reportable Segment        
Segment Reporting Information, Profit (Loss) [Abstract]        
Compensation and benefits 7,930 9,844 14,299 16,957
Lab and equipment 3,074 1,757 8,883 3,087
General and administrative 4,091 2,718 7,993 7,548
Professional fees 6,080 2,233 12,165 4,252
Facility 1,444 2,998 2,991 4,026
Marketing and sales 191 275 378 442
Total operating expenses 25,607 24,627 53,437 45,898
Operating Segments | Single Reportable Segment        
Segment Reporting Information, Profit (Loss) [Abstract]        
Stock compensation $ 2,797 $ 4,802 $ 6,728 $ 9,586
v3.25.2
Segment and Geographic Information - Geographic Information (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2025
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | Asia Pacific    
Segment Reporting Information [Line Items]    
Concentration risk percentage 100.00% 100.00%
v3.25.2
Subsequent Events (Details) - Subsequent Event - UZ Energy Co., Ltd.
¥ in Thousands
2 Months Ended
Jul. 25, 2025
Sep. 30, 2025
CNY (¥)
Sep. 30, 2025
USD ($)
Business Combination, Description [Abstract]      
Business combination, name of acquiree UZ Energy Co., Ltd.    
Business combination, date of acquisition agreement Jul. 25, 2025    
Forecast      
Business Combination, Description [Abstract]      
Business combination, voting equity interest acquired, percentage (as a percent)   100.00% 100.00%
Business Combination, Consideration Transferred [Abstract]      
Business combination, consideration transferred   ¥ 183,460 $ 25,480,556
Business combination, consideration transferred, equity interest   ¥ 90,000 $ 12,500,000